Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)

169
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
07/17/2014 07/18/2014 07/21/2014 07/22/2014 07/23/2014 Date
264(c) 262.3(c) 263.3(c) 266(c) 266.5(c) Last
901 985 980 486 807 877 658 943 812 380 Volume
-0.90% -0.64% +0.38% +1.03% +0.19% Change
More quotes
Company
Roche Holding AG is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. As a large biotech company, Roche has truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. It is also a leader in in-vitro... 
Sector
Pharmaceuticals
Calendar
07/24 | 01:00amEarnings Release
Surperformance© rating of Roche Holding Ltd.
Trading Rating : Investor Rating :
More about the company
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Full-screen chart
Financials ( CHF)
Sales 2014 47 373 M
EBIT 2014 17 533 M
Net income 2014 12 206 M
Debt 2014 2 765 M
Yield 2014 3,13%
Sales 2015 49 242 M
EBIT 2015 18 603 M
Net income 2015 13 086 M
Finance 2015 3 002 M
Yield 2015 3,37%
PER 2014 18,32
PER 2015 16,95
EV / Sales 2014 4,83x
EV / Sales 2015 4,53x
Capitalization 226 105 M
More Financials
Latest news on ROCHE HOLDING LTD.
1d agoDJRoche Holding AG 1st Half 2014 -- Forecast
1d ago ROCHE : FDA Grants Genentech’s Avastin Priority Review for Recurrent Plati..
4d agoDJRoche Not Interested in Large Acquisitions, Says CEO -- Report
4d ago Roche CEO plans to steer clear of big acquisitions
07/15 ROCHE : FDA Grants Genentech’s Avastin Priority Review for Certain Types o..
07/14 ROCHE : Genentech :’s Investigational Medicine Cobimetinib, Used in Combin..
07/02DJEUROPE MARKETS : Alcatel Higher In Europe, But Orange Shares Sour
07/02DJEUROPE MARKETS : Alcatel, Roche Up In Europe, But Orange Shares Sour
07/02 GLAXOSMITHKLINE : Cameron enlists ex-Goldman economist in global superbug fight
07/02 JOHNSON & JOHNSON : Roche to buy U.S. biotech firm Seragon for up to $1.7 billio..
07/02DJGenentech to Buy Seragon Pharma For up to $1.725 Billion
07/02DJROCHE : Genentech to Buy Seragon Pharmaceuticals for up to $1.725 Billion
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
Roche Holding Ltd. : Income Statement Evolution
More Financials
EPS Revisions
Roche Holding Ltd. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF